BioWorld

Feb. 16, 2001

View Archived Issues

Appointments And Advancements

Read More

EntreMed Starts Another Phase II Study Of 2ME2, In Prostate Cancer

Read More

Atrix Puts 4M Shares On Shelf To Fund Corporate Activities

Read More

Holiday Notice

Read More

Other News To Note

Read More

AEterna Enters $23M Deal For European Rights To Neovastat

Read More

Law Professor Questions Privacy Rules Scheduled To Become Law

Read More

Praecis Offering Nets $150M For Abarelix, Other Products

Read More

Corixa Falls On Mixed Phase II Results Of PVAC In Psoriasis

Read More